首页|拉考沙胺联合高压氧治疗病毒性脑炎合并癫痫患者的效果

拉考沙胺联合高压氧治疗病毒性脑炎合并癫痫患者的效果

扫码查看
目的 研究拉考沙胺联合高压氧对病毒性脑炎(VE)合并癫痫患者的疗效及对神经功能、免疫功能的影响.方法 选取2021年1月至2023年1月郑州大学第一附属医院收治的92例VE合并癫痫患者为研究对象,根据治疗方案将患者分为参照组和试验组,每组46例.参照组接受高压氧治疗,试验组接受拉考沙胺联合高压氧治疗.比较两组临床疗效、临床症状改善时间、治疗前后免疫功能指标(CD3+、CD4+、CD8+、CD4+/CD8+)、血清神经功能指标[神经元特异性烯醇化酶(NSE)、中枢神经特异性蛋白S100β、髓鞘碱性蛋白(MBP)、脑源性神经营养因子(BDNF)]水平、血清白细胞介素(IL-6、IL-1β)、T细胞正常表达和分泌刺激因子(RANTES)、嗜酸性粒细胞趋化因子(Eotaxin)水平.结果 试验组临床总有效率(97.83%)高于参照组(82.61%),差异有统计学意义(P<0.05);试验组体温恢复、惊厥消失、脑膜刺激征消失、意识恢复时间均短于参照组,差异有统计学意义(P<0.05);与参照组相比,治疗后试验组CD3+、CD4+、CD4+/CD8+水平较高,CD8+水平较低,差异有统计学意义(P<0.05);与参照组相比,治疗后试验组血清NSE、S100β、MBP水平降低,BDNF水平升高,差异有统计学意义(P<0.05);与治疗前相比,两组治疗后血清IL-6、IL-1 β、RANTES、Eotaxin水平降低,其中试验组更低,差异有统计学意义(P<0.05).结论 拉考沙胺联合高压氧对VE合并癫痫患者疗效确切,可改善临床症状,减轻炎症反应及神经损伤,提高免疫功能,促进患者病情恢复.
Effect of Lacoxamide Combined with Hyperbaric Oxygen in Patients with Viral Encephalitis Complicated with Epilepsy
Objective To study the efficacy of lacoxamide combined with hyperbaric oxygen in patients with viral encephalitis(VE)complicated with epilepsy,and the effects on nervous function and immune function.Methods Ninety-two cases of VE patients with epilepsy admitted to the First Affiliated Hospital of Zhengzhou University from January 2021 to January 2023 were selected as research objects.According to the treatment plan,the patients were divided into the reference group and the experimental group,46 cases in each group.The control group was treated with hyperbaric oxygen,and the experimental group was treated with lacoxamine combined with hyperbaric oxygen.Clinical efficacy,improvement time of clinical symptoms,immune function indexes(CD3+,CD4+,CD8+,CD4+/CD8+),serum neural function indexes[neuron-specific enolase(NSE),central nervous specific protein S100β,myelin basic protein(MBP),brain-derived neurotrophic factor(BDNF)],serum interleukin(IL-6,IL-1β),the regulated upon activation normal T cell expressed and secreted(RANTES),and eosinophil chemokines(Eotaxin)before and after treatment of two groups were compared.Results The total effective rate of the experimental group(97.83%)was higher than that of the control group(82.61%),and the difference was statistically significant(P<0.05).The recovery time of body temperature,disappearance of convulsion,disappearance of meningeal stimulation and recovery of consciousness in the experimental group were shorter than those in the control group,and the difference was statistically significant(P<0.05).Compared with the control group,the levels of CD3+,CD4+,CD4+/CD8+were higher in the experimental group after treatment,and the levels of CD8+were lower,the difference was statistically significant(P<0.05).Compared with the control group,the serum levels of NSE,S100β and MBP in the experimental group were decreased after treatment,while the level of BDNF was increased,with statistical significance(P<0.05).Compared with before treatment,serum levels of IL-6,IL-1 β,RANTES and Eotaxin in the two groups were decreased after treatment,the experimental group was lower,the difference was statistically significant(P<0.05).Conclusion Lacoxamine combined with hyperbaric oxygen is effective in VE patients with epilepsy.It can improve clinical symptoms,reduce inflammatory response and nerve damage,improve immune function,and promote the recovery of the disease.

viral encephalitislacoxamidehyperbaric oxygenepilepsyneural function

郑婷婷、谢娜、袁萍、李玉生

展开 >

郑州大学第一附属医院神经内五科,河南郑州 450000

病毒性脑炎 拉考沙胺 高压氧 癫痫 神经功能

2021年河南省医学科技攻关省部共建重点项目

SBGJ202101016

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(7)
  • 16